Request Demo
Last update 07 Jun 2025
1928z-E27
Last update 07 Jun 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with 1928z-E27NCT05574114
A Phase I Study Of Split-Course Bridging Radiotherapy (SC-BRT) Prior To Commercial CD19 CAR T-Cell Therapies For Patients With Relapsed or Refractory B-Cell Lymphomas
NCT04556266
A Phase I Trial Evaluating the Safety of Consolidative Infusions of CD19-Specific Chimeric Antigen Receptor (CAR) T Cells Following T-cell Depleted Allogeneic Transplantation for High Risk B-cell Malignancies
100 Clinical Results associated with 1928z-E27
Login to view more data
100 Translational Medicine associated with 1928z-E27
Login to view more data
100 Patents (Medical) associated with 1928z-E27
Login to view more data
100 Deals associated with 1928z-E27
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diffuse Large B-Cell Lymphoma | Phase 1 | United States | 05 Oct 2022 | |
| High grade B-cell lymphoma | Phase 1 | United States | 05 Oct 2022 | |
| Mediastinal large B-cell lymphoma | Phase 1 | United States | 05 Oct 2022 | |
| Non-Hodgkin's lymphoma refractory | Phase 1 | United States | 05 Oct 2022 | |
| Recurrent Non-Hodgkin Lymphoma | Phase 1 | United States | 05 Oct 2022 | |
| CD19 Expressing Malignancies | Phase 1 | United States | 01 Jul 2021 | |
| Chronic Lymphocytic Leukemia | Phase 1 | United States | 01 Jul 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free